World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
59
Citations
12569
World Ranking
3425
National Ranking
1590

Victor Ghetie publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Victor Ghetie sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 160 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Victor Ghetie D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Victor Ghetie sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Victor Ghetie is affiliated with The University of Texas Southwestern Medical Center in the United States. Their academic career is centered around research work conducted at this institution, contributing to the body of medical and scientific knowledge associated with this center.

Available data do not list recent papers, co-authors, or frequent publication venues, which suggests a limited public record of collaborative outputs or a focus on other scholarly activities. Similarly, no information about specific fields of study, subfields, or main research topics has been documented for their profile.

There are no recorded awards, book publications, or recognized accolades associated with their career at this time. The absence of detailed publication or citation data indicates that either their work is emerging, specialized in niche areas, or not broadly disseminated in indexed sources.

Their professional contributions remain affiliated with an academic medical center known for clinical and translational research, implying involvement in areas related to biomedical sciences or medicine, although precise focus areas are not specified. This affiliation places them within a research environment known for a range of medical disciplines.

Due to the limited publicly available information, it is not possible to list concrete scientific topics, co-author networks, or publication venues. The profile reflects a scholar affiliated with a major U.S. medical research institution without additional detailed records accessible at this time.

Best Publications

  • Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies.

    Raimund J. Ober;Caius G. Radu;Victor Ghetie;E. Sally Ward

  • Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient mice

    Victor Ghetie;James G. Hubbard;Jin Kyoo Kim;May Fang Tsen

  • Multiple Roles for the Major Histocompatibility Complex Class I– Related Receptor FcRn

    Unknown

  • Increasing the serum persistence of an IgG fragment by random mutagenesis.

    Victor Ghetie;Serguei Popov;Jozef Borvak;Caius Radu

  • Phase I immunotoxin trial in patients with B-cell lymphoma.

    Ellen S. Vitetta;Marvin Stone;Peter Amlot;Joseph Fay

  • The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans

    Mihail Firan;Roger Bawdon;Caius Radu;Raimund J. Ober

  • FcRn: the MHC class I-related receptor that is more than an IgG transporter.

    Victor Ghetie;E.Sally Ward

  • A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy

    P. L. Amlot;M. J. Stone;D. Cunningham;J. Fay

  • Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor

    Jin‐Kyoo ‐K Kim;May‐Fang ‐F Tsen;Victor Ghetie;E. Sally Ward

  • Mapping the site on human IgG for binding of the MHC class I-related receptor, FcRn

    Jin-Kyoo Kim;Mihail Firan;Caius G. Radu;Cheol-Hong Kim

  • Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice.

    J Borvak;J Richardson;C Medesan;C Medesan;F Antohe

  • Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans

    E. Sally Ward;Jinchun Zhou;Victor Ghetie;Raimund J. Ober

  • Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome

    Roxana Baluna;Josep Rizo;Brian E. Gordon;Victor Ghetie

  • Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

    Persis J. Amrolia;Giada Muccioli-Casadei;Helen Huls;Stuart Adams

  • Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site‐directed mutagenesis

    Jin‐Kyoo Kim;May‐Fang Tsen;Victor Ghetie;E. Sally Ward

  • HIV-infected cells are killed by rCD4-ricin A chain

    Mark A. Till;Victor Ghetie;Timothy Gregory;Eric J. Patzer

  • Evaluation of Ricin A Chain-containing Immunotoxins Directed against CD19 and CD22 Antigens on Normal and Malignant Human B-Cells as Potential Reagents for in Vivo Therapy

    Maria-Ana Ghetie;Richard D. May;Mark Till;Jonathan W. Uhr

  • Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1.

    C Medesan;D Matesoi;C Radu;V Ghetie

  • A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma

    Marvin J. Stone;Edward A. Sausville;Joseph W. Fay;Donna Headlee

  • A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.

    Andreas Engert;Volker Diehl;Volker Diehl;Roland Schnell;Roland Schnell;Andrea Radszuhn;Andrea Radszuhn

  • Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

    Scott R. Solomon;Stephan Mielke;Stephan Mielke;Bipin N. Savani;Bipin N. Savani;Aldemar Montero;Aldemar Montero

Frequent Co-Authors

Ellen S. Vitetta
Ellen S. Vitetta The University of Texas Southwestern Medical Center
E. Sally Ward
E. Sally Ward University of Southampton
Jonathan W. Uhr
Jonathan W. Uhr The University of Texas Southwestern Medical Center
Caius G. Radu
Caius G. Radu University of California, Los Angeles
Philip E. Thorpe
Philip E. Thorpe The University of Texas Southwestern Medical Center
Andreas Engert
Andreas Engert University of Cologne
Volker Diehl
Volker Diehl University of Cologne
George Janossy
George Janossy University of the Witwatersrand
James A. Richardson
James A. Richardson The University of Texas Southwestern Medical Center
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology in the USA opens up numerous avenues for specialized healthcare careers. Many professionals transition into nursing roles that complement their scientific background, enhancing patient care through advanced knowledge. For instance, those working as Family Nurse Practitioners (FNPs) can elevate their expertise by obtaining an acute care certification for FNP, allowing them to manage complex, critical health conditions effectively.

For individuals aiming to progress faster in nursing, accelerated pathways offer a practical solution. Programs like the accelerated RN to NP programs provide a streamlined curriculum that helps registered nurses become Nurse Practitioners more efficiently.

Additionally, people from non-nursing backgrounds interested in healthcare can enroll in online BSN programs for non nurses, offering flexible learning opportunities that bridge the gap between different disciplines.

Choosing the right program is crucial. Students often seek out the easiest ABSN program to get into to ensure a smoother admission process without compromising educational quality. These online pathways support aspiring healthcare professionals in aligning their Immunology knowledge with impactful nursing roles.

Best Scientists Citing Victor Ghetie

Trending Scientists

Recently Published Articles